126 related articles for article (PubMed ID: 15301685)
21. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
[TBL] [Abstract][Full Text] [Related]
23. Occult hepatitis B virus and hepatitis C virus infections.
Carreño V; Bartolomé J; Castillo I; Quiroga JA
Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
[TBL] [Abstract][Full Text] [Related]
24. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
25. Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection.
Robaeys G; Nevens F; Stärkel P; Colle I; Van Eyken P; Bruckers L; Van Ranst M; Buntinx F
Transplant Proc; 2009 Mar; 41(2):589-94. PubMed ID: 19328933
[TBL] [Abstract][Full Text] [Related]
26. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
27. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
[TBL] [Abstract][Full Text] [Related]
29. Change in hepatitis C virus genotype in injecting drug users.
Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M
J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265
[TBL] [Abstract][Full Text] [Related]
30. Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C.
Chen SW; Lee TS; Hu CC; Chang LC; Chien RN
Scand J Infect Dis; 2007; 39(4):351-4. PubMed ID: 17454901
[TBL] [Abstract][Full Text] [Related]
31. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
33. Anti-hepatitis C virus-positive blood donors: are women any different?
Narciso-Schiavon JL; Schiavon LL; Carvalho-Filho RJ; Freire FC; Cardoso JR; Bordin JO; Silva AE; Ferraz ML
Transfus Med; 2008 Jun; 18(3):175-83. PubMed ID: 18598280
[TBL] [Abstract][Full Text] [Related]
34. Occult hepatitis B in renal transplant patients.
Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
36. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
37. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
38. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
39. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.
Gordon SC; Elloway RS; Long JC; Dmuchowski CF
Hepatology; 1993 Dec; 18(6):1338-43. PubMed ID: 8244258
[TBL] [Abstract][Full Text] [Related]
40. Changing HCV genotypes distribution in Poland--relation to source and time of infection.
Chlabicz S; Flisiak R; Kowalczuk O; Grzeszczuk A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Clin Virol; 2008 Jun; 42(2):156-9. PubMed ID: 18353714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
